Literature DB >> 18928375

Molecular epidemiology and interferon susceptibility of the natural recombinant hepatitis C virus strain RF1_2k/1b.

Fuat Kurbanov1, Yasuhito Tanaka, Elena Chub, Isao Maruyama, Aziza Azlarova, Hiroshi Kamitsukasa, Tomoyoshi Ohno, Stefania Bonetto, Isabelle Moreau, Liam J Fanning, Florence Legrand-Abravanel, Jaques Izopet, Nikolai Naoumov, Takashi Shimada, Sergei Netesov, Masashi Mizokami.   

Abstract

BACKGROUND: Hepatitis C virus (HCV) genotype is an important determinant of virological response to antiviral therapies. Currently, there are no data available on the molecular epidemiology and interferon susceptibility of the natural intergenotypic recombinant RF1_2k/1b (RF1) strain.
METHODS: Genotyping and RF1-PCR screening were performed on samples from 604 HCV RNA-positive individuals from 7 countries. uPA/SCID mice carrying human hepatocytes (chimeric mice) were infected with the RF1_2k/1b strain, and the susceptibility of the strain to interferon and ribavirin was compared with the susceptibilities of 2 different strains of genotype B, used as references.
RESULTS: Six new RF1 cases were identified in this study; 5 (2%) of 281 in Russia and 1 (1%) of 90 in Uzbekistan. Phylogenetic analyses based on Core/E1 and NS5b indicated that all RF1 representatives share a common evolutionary ancestor. Infection with RF1 was established in chimeric mice. Reduction of RF1 viral load was observed in response to 3 injections of 3 microg/kg pegylated-interferon alpha-2a alone or in combination with 50 mg/kg of ribavirin (0.5 or 1.4 log-copies/mL).
CONCLUSIONS: All identified RF1-type strains appear to be introduced from a single source, suggesting that intergenotypic recombination in HCV is sporadic and not associated with cocirculation of different genotypes in a population. The RF1 strain in this study was responsive to interferon in vivo.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18928375     DOI: 10.1086/592757

Source DB:  PubMed          Journal:  J Infect Dis        ISSN: 0022-1899            Impact factor:   5.226


  13 in total

1.  High incidence of the hepatitis C virus recombinant 2k/1b in Georgia: Recommendations for testing and treatment.

Authors:  Marine Karchava; Jesper Waldenström; Monica Parker; Renee Hallack; Lali Sharvadze; Lana Gatserelia; Nikoloz Chkhartishvili; Natia Dvali; Lela Dzigua; Ekaterine Dolmazashvili; Helene Norder; Tengiz Tsertsvadze
Journal:  Hepatol Res       Date:  2015-03-24       Impact factor: 4.288

2.  Origin and evolution of the unique hepatitis C virus circulating recombinant form 2k/1b.

Authors:  Jayna Raghwani; Xiomara V Thomas; Sylvie M Koekkoek; Janke Schinkel; Richard Molenkamp; Thijs J van de Laar; Yutaka Takebe; Yasuhito Tanaka; Masashi Mizokami; Andrew Rambaut; Oliver G Pybus
Journal:  J Virol       Date:  2011-11-23       Impact factor: 5.103

3.  Successful direct-acting antiviral treatment of three patients with genotype 2/1 recombinant hepatitis C virus.

Authors:  Masako Okada; Hoang Hai; Akihiro Tamori; Sawako Uchida-Kobayashi; Masaru Enomoto; Hiromitsu Kumada; Norifumi Kawada
Journal:  Clin J Gastroenterol       Date:  2018-11-16

4.  Naturally occurring genotype 2b/1a hepatitis C virus in the United States.

Authors:  Dipankar Bhattacharya; Molly A Accola; Israr H Ansari; Rob Striker; William M Rehrauer
Journal:  Virol J       Date:  2011-10-03       Impact factor: 4.099

5.  Stability of yellow fever virus under recombinatory pressure as compared with chikungunya virus.

Authors:  Charles E McGee; Konstantin A Tsetsarkin; Bruno Guy; Jean Lang; Kenneth Plante; Dana L Vanlandingham; Stephen Higgs
Journal:  PLoS One       Date:  2011-08-03       Impact factor: 3.240

6.  Near-full genome characterisation of two natural intergenotypic 2k/1b recombinant hepatitis C virus isolates.

Authors:  Victoria L Demetriou; Eftychia Kyriakou; Leondios G Kostrikis
Journal:  Adv Virol       Date:  2011-05-15

7.  Molecular epidemiology of hepatitis C infection in Cyprus within the general population and high-risk cohorts.

Authors:  Victoria L Demetriou; Leondios G Kostrikis
Journal:  BMC Res Notes       Date:  2011-10-31

8.  Expanded classification of hepatitis C virus into 7 genotypes and 67 subtypes: updated criteria and genotype assignment web resource.

Authors:  Donald B Smith; Jens Bukh; Carla Kuiken; A Scott Muerhoff; Charles M Rice; Jack T Stapleton; Peter Simmonds
Journal:  Hepatology       Date:  2014-01       Impact factor: 17.425

9.  Hepatitis C virus kinetics by administration of pegylated interferon-α in human and chimeric mice carrying human hepatocytes with variants of the IL28B gene.

Authors:  Tsunamasa Watanabe; Fuminaka Sugauchi; Yasuhito Tanaka; Kentaro Matsuura; Hiroshi Yatsuhashi; Shuko Murakami; Sayuki Iijima; Etsuko Iio; Masaya Sugiyama; Takashi Shimada; Masakazu Kakuni; Michinori Kohara; Masashi Mizokami
Journal:  Gut       Date:  2012-11-07       Impact factor: 23.059

10.  Heads or Tails: Genotyping of Hepatitis C Virus Concerning the 2k/1b Circulating Recombinant Form.

Authors:  Wim Schuermans; Hans Orlent; Isabelle Desombere; Patrick Descheemaeker; Hans Van Vlierberghe; Anja Geerts; Xavier Verhelst; Marijke Reynders; Elizaveta Padalko
Journal:  Int J Mol Sci       Date:  2016-08-23       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.